Literature DB >> 24488066

CrossTalk proposal: The late sodium current is an important player in the development of diastolic heart failure (heart failure with a preserved ejection fraction).

Marc Pourrier1, Sarah Williams, Donald McAfee, Luiz Belardinelli, David Fedida.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24488066      PMCID: PMC3930422          DOI: 10.1113/jphysiol.2013.262261

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  32 in total

Review 1.  Pathophysiology and pharmacology of the cardiac "late sodium current.".

Authors:  Antonio Zaza; Luiz Belardinelli; John C Shryock
Journal:  Pharmacol Ther       Date:  2008-07-01       Impact factor: 12.310

2.  Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts.

Authors:  Heather Fraser; Luiz Belardinelli; Lianguo Wang; Peter E Light; Jeffrey J McVeigh; Alexander S Clanachan
Journal:  J Mol Cell Cardiol       Date:  2006-10-05       Impact factor: 5.000

3.  Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy.

Authors:  Raffaele Coppini; Cecilia Ferrantini; Lina Yao; Peidong Fan; Martina Del Lungo; Francesca Stillitano; Laura Sartiani; Benedetta Tosi; Silvia Suffredini; Chiara Tesi; Magdi Yacoub; Iacopo Olivotto; Luiz Belardinelli; Corrado Poggesi; Elisabetta Cerbai; Alessandro Mugelli
Journal:  Circulation       Date:  2012-12-27       Impact factor: 29.690

4.  Increased late sodium current in myocytes from a canine heart failure model and from failing human heart.

Authors:  Carmen R Valdivia; William W Chu; Jielin Pu; Jason D Foell; Robert A Haworth; Mathew R Wolff; Timothy J Kamp; Jonathan C Makielski
Journal:  J Mol Cell Cardiol       Date:  2005-03       Impact factor: 5.000

Review 5.  Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.

Authors:  Barry A Borlaug; Walter J Paulus
Journal:  Eur Heart J       Date:  2010-12-07       Impact factor: 29.983

6.  Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease.

Authors:  W Hayashida; C van Eyll; M F Rousseau; H Pouleur
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

7.  Ventricular dysfunction in a family with long QT syndrome type 3.

Authors:  Yoran M Hummel; Arthur A M Wilde; Adriaan A Voors; Silvia Bugatti; Hans L Hillege; Maarten P van den Berg
Journal:  Europace       Date:  2013-04-23       Impact factor: 5.214

8.  Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure.

Authors:  Hani N Sabbah; Margaret P Chandler; Takayuki Mishima; George Suzuki; Pervaiz Chaudhry; Omar Nass; Brandon J Biesiadecki; Brent Blackburn; Andrew Wolff; William C Stanley
Journal:  J Card Fail       Date:  2002-12       Impact factor: 5.712

Review 9.  New treatment options for late Na current, arrhythmias, and diastolic dysfunction.

Authors:  Lars S Maier
Journal:  Curr Heart Fail Rep       Date:  2012-09

10.  Resveratrol attenuates the Na(+)-dependent intracellular Ca(2+) overload by inhibiting H(2)O(2)-induced increase in late sodium current in ventricular myocytes.

Authors:  Chunping Qian; Jihua Ma; Peihua Zhang; Antao Luo; Chao Wang; Zhiqiang Ren; Linghao Kong; Shuo Zhang; Xiaojing Wang; Ying Wu
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

View more
  7 in total

1.  Rebuttal from Zoltan Papp, Attila Borbely and Walter J. Paulus.

Authors:  Zoltán Papp; Attila Borbély; Walter J Paulus
Journal:  J Physiol       Date:  2014-02-01       Impact factor: 5.182

Review 2.  Targets for therapy in sarcomeric cardiomyopathies.

Authors:  Jil C Tardiff; Lucie Carrier; Donald M Bers; Corrado Poggesi; Cecilia Ferrantini; Raffaele Coppini; Lars S Maier; Houman Ashrafian; Sabine Huke; Jolanda van der Velden
Journal:  Cardiovasc Res       Date:  2015-01-29       Impact factor: 10.787

3.  Arrhythmogenic and antiarrhythmic actions of late sustained sodium current in the adult human heart.

Authors:  Anh Tuan Ton; William Nguyen; Katrina Sweat; Yannick Miron; Eduardo Hernandez; Tiara Wong; Valentyna Geft; Andrew Macias; Ana Espinoza; Ky Truong; Lana Rasoul; Alexa Stafford; Tamara Cotta; Christina Mai; Tim Indersmitten; Guy Page; Paul E Miller; Andre Ghetti; Najah Abi-Gerges
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

4.  Scn1b expression in the adult mouse heart modulates Na+ influx in myocytes and reveals a mechanistic link between Na+ entry and diastolic function.

Authors:  Daniel O Cervantes; Emanuele Pizzo; Harshada Ketkar; Sreema P Parambath; Samantha Tang; Eleonora Cianflone; Antonio Cannata; Govindaiah Vinukonda; Sudhir Jain; Jason T Jacobson; Marcello Rota
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-04-08       Impact factor: 4.733

5.  Changes in Intracellular Na+ following Enhancement of Late Na+ Current in Virtual Human Ventricular Myocytes.

Authors:  Karen Cardona; Beatriz Trenor; Wayne R Giles
Journal:  PLoS One       Date:  2016-11-22       Impact factor: 3.240

6.  Dynamics of sodium current mediated early afterdepolarizations.

Authors:  Daisuke Sato; Colleen E Clancy; Donald M Bers
Journal:  Heliyon       Date:  2017-09-06

7.  Late sodium current and calcium homeostasis in arrhythmogenesis.

Authors:  Kornél Kistamás; Tamás Hézső; Balázs Horváth; Péter P Nánási
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.